Ischemic and nonischemic heart failure do not require different treatment strategies

Journal of Cardiovascular Pharmacology

Volumn 33, Issue SUPPL. 3, 1999, Pages

  Abraham, William T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

ACE inhibitor; Beta blocker; Coronary artery disease; Dilated cardiomyopathy; Heart failure; Therapy

Indexed keywords

AMIODARONE; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; PLACEBO;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HEART LEFT VENTRICLE FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VALVULAR HEART DISEASE;

CARDIAC OUTPUT, LOW; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 0032806060     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199906003-00001     Document Type: Conference Paper

References (4)

1. Cohn JN. The management of chronic heart failure. W Engl J Med 1996;335:490-498.
2. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141.
3. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-243.
4. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A, for the V-HeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relation to survival and the effects of therapy in V-HeFT II. Circulation 1993;87 (suppl VI):VI40-VI48.